Pulmonary Predicaments in Primary Care Peter F. Bidey, DO
|
|
- Iris Morton
- 5 years ago
- Views:
Transcription
1 Pulmonary Predicaments in Primary Care Peter F. Bidey, DO
2
3 Pulmonary Predicaments in Primary Care Peter F. Bidey, D.O. Clinical Instructor -Family Medicine Philadelphia College of Osteopathic Medicine ACOFP Intensive Update and Board Review August 22, 2015 Chicago, IL Objectives Examine and differentiate asthma and COPD diagnosis and treatments Review diagnosis and treatment of pulmonary tuberculosis in out-patient setting Review diagnosis and treatment of community acquired pneumonia in out-patient setting Case A 45 year old male presents to your office complaining of wheeze and DOE over the past year. Patient states he remembers having some issues with asthma as a child but no issues for many years. He reports a 10 pack year history of tobacco use and quit smoking 15 years ago. He states his mother has COPD and his father has asthma. 1
4 Case Asthma or COPD? How would management change? Thorax 2008;63: doi: /thx Asthma Definition Chronic disorder with recurring symptoms of airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation It is a reversible obstructive lung disease Symptoms Wheeze Cough Shortness of breath Chest tightness Asthma Diagnosis History Episodic and trigger-induced wheeze, SOB, DOE, and cough Family History and/or personal history as child Physical Exam Wheeze Atopic dermatitis and allergic rhinitis Viscerosomatic reflexes, diaphragmatic disorders, and rib dysfunctions 2
5 Asthma Diagnosis cont. Studies Spirometry Pre-and Post-bronchodilator Methacholine Challenge Good for patients with normal baseline airflow Peak Expiratory Flow Meter Better for monitoring known disease Labs Chest radiograph Differential Diagnosis Children Allergic rhinitis Recurrent bronchitis Vocal chord dysfunction GERD Recurrent aspiration Laryngotracheomalacia Bronchiolitis Cystic fibrosis Panic disorder Adults Rhinosinusitits COPD Vocal chord dysfunction CHF GERD PE Tumor Drug induced cough Sarcoidosis Asthma Classification Mild Intermittent Mild Persistent Symptoms 2days/week >2 days/week but not daily Rescue inhaler Use Nighttime awaking Interference with activity Lung function 2days/week >2days/week but not daily Moderate Persistent Daily Daily 2x/month 3-4x/month >1x/week but not nightly Severe Persistent Throughout day Several times /day Often 7x/week None Minor Some Very limited FEV1>80% predicted FEV1/FVC normal FEV1>80% predicted FEV1/FVC normal FEV1>60% but <80% predicted FEV1/FVC reduced 5% FEV1<60% predicted FEV1/FVC reduced >5% 3
6 Chronic Obstructive Pulmonary Disease Definition Airflow limitation that is progressive and associated with an enhanced chronic inflammatory response in the airways and lungs to noxious particles and gases Includes sub-types: emphysema, chronic bronchitis, and chronic obstructive asthma 210 million diagnosed worldwide and by 2030 will be 3 rd most common cause of death in the world Symptoms Chronic progressive-cough, sputum production, and dyspnea COPD Diagnosis History Smoking and inhalation exposure Progressive DOE, chronic cough, and increase in sputum production Physical Exam Early disease is usually normal Hyperinflation, decreased breath sounds, wheezes, decreased heart sounds, and crackles at bases Severe disease results in barrel chest, flattening of the diaphragm, and pursed lip breathing COPD Diagnosis cont. Studies Spirometry FEV1/FVC < 0.70 or 5% lower limit of normal(lln) Post-bronchodilator Chest radiograph vs. CT scan Lab tests Can consider: ABG-FEV1 <50% predicted or pulse ox <92% CBC/CMP α-1 antitrypsin 4
7 Spirometry Results Differential Diagnosis Asthma Tumor Heart failure Bronchiectasis Tuberculosis Sleep apnea Restrictive lung disease Interstitial lung disease GOLD Criteria Classification of Severity Global Initiative for Chronic Obstructive Lung Disease All have FEV1/FVC<0.7 or <5%LLN of FEV1/FVC GOLD 1-Mild FEV1 80% predicted GOLD 2-Moderate GOLD 3-Severe GOLD 4-Very Severe FEV1 50% predicted and <80% predicted FEV1 30% predicted and <50% predicted FEV1<30% predicted 5
8 GOLD Disease Category Combines FEV1 level with symptoms and history of exaggerations Individual symptoms Uses modified Medical Research Council (mmrc) or COPD or COPD assessment test (CAT) Number of exacerbations in 12 months Combined Assessment of COPD Tashkin & FergusonRespiratory Research. 2013;14(49) 2013 BioMedCentral, Ltd. - Accessed July 7, 2015 Case A 45 year old male presents to your office complaining of wheeze and DOE over the past year. Patient states he remembers having some issues with asthma as a child but no issues for many years. He reports a 10 pack year history of tobacco use and quit smoking 15 years ago. He states his mother has COPD and his father has asthma. Asthma or COPD? Still undecided? 6
9 Asthma Treatment Goal Daytime symptoms <2x/week and nighttime symptoms <2x month Avoid triggers Vaccines Influenza and Pneumococcal recommendations Stepwise treatment fashion Rescue inhaler use with short-acting β-2 agonists (SABA) Acute exaggerations usually require systemic steroids Asthma action plan Mild Intermittent Asthma No controller medication needed SABA PRN Albuterol MDI with spacer as effective as nebulized solution as well as more cost effective Mild Persistent Asthma Maintenance medication using low-dose inhaled corticosteroids (ICS) Can consider asthma action plan Can consider leukotriene receptor antagonists 7
10 Moderate Persistent Asthma Maintenance medications using low-dose ICS with: Long-acting β-2 agonists (LABA) Leukotriene modifiers Cromolyn OR Maintenance medication using medium-dose ICS Severe Persistent Asthma Maintenance medications using high-dose ICS and LABAs Can consider all other add-ons including theophylline and immunotherapy Can consider oral corticosteroids but want to limit long term use Exercise-Induced Asthma Symptoms similar to asthma but usually only associated with exercise Treat with SABA 10 minutes prior to exercise Minimize irritant exposure and can consider leukotriene modifiers 8
11 Asthma Treatment Summary National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, National Heart, Lung, and Blood Institute. August NIH publication COPD Treatment-Stable Patients STOP smoking or exposure to other irritants Step-wise treatment fashion Pulmonary Rehabilitation Vaccines Influenza Pneumococcal Oxygen therapy for patient with severe hypoxemia COPD Treatment Patient Group A B C First Choice Second Choice Alternatives Short-acting anticholinergic PRN or SABA PRN Long acting anticholinergic or LABA ICS & LABA or Longacting anticholinergic LAMA or LABA or SABA & SAMA LAMA & LABA LAMA & LABA or LAMA & PDE 4 or LABA & PDE 4 Theophylline SAMA PRN &/0r SABA PRN Theophylline SAMA &/0r SABA Theophylline D ICS & LABA &/or Long-acting anticholinergic ICS & LABA & LAMA or ICS & LABA & PDE4 or LAMA & LABA or LAMA & PDE4 SAMA PRN &/0r SABA PRN Theophylline Carbocysteine 9
12 Acute COPD Exacerbations Systemic Steroids Bronchodilators Antibiotics BiPAP vs. mechanical ventilation Osteopathic Treatments Release the diaphragm Correct rib lesions Lymphatic pumps Rib raising Case A 27 year old female medical student presents to have TST read 48 hours after administration. She was exposed to a patient with confirmed active tuberculosis 8 weeks ago on her Emergency Medicine rotation. Initial TST was negative. Today, the induration measures 14 mm. She denies any systemic symptoms and is otherwise without complaints. She has no significant past medical history. A CXR was ordered and shows no abnormalities. She has no history of positive TST or previous BCG vaccination. Diagnosis and Treatment? 10
13 Pulmonary Tuberculosis-Latent History Testing should be performed in patients with recent contact and who are at high risk of conversion Diagnosis in HIV-negative patients Tuberculin Skin Test Preferred test for children <5 Interferon Gamma Release Assays Can be used in all settings in place of TST. Preferred test in BCG-vaccinated individuals Possible use for determining false positives Two-Step Testing Performed 1 to 4 weeks after initial testing in absence of exposure Pulmonary Tuberculosis-Latent Treatment Goal To avoid conversion to active tuberculosis Additional Tests Obtain CXR, HIV testing, pregnancy, and baseline LFTs Monitor for any signs of active tuberculosis Medications Isoniazid +/- pryidoxine for 9 months Can consider alternative treatments of INH with rifapentine for 3 months if recent exposure >12 years old Direct observation treatment Interpretation of Tuberculin Skin Test 5mm HIV infection, close contact of active contagious case, Abnormal CXR consistent with old TB, or immunosuppressed patients 10mm High risk of reactivation-silicosis, ESRD, DM, leukemia, lymphoma, head/neck/lung CA, underweight, jejunoileal bypass, IV-drug user Children <4 years of age Foreign born from countries with incidence >25/ Residents and employees in high risk settings 15mm Healthy persons with low likelihood of true TB infection 11
14 Case A 37 year old male social worker presents with recent 10lb weight loss over the past six months as well as fatigue. He states recently he has noticed some night sweats and has recently developed a cough. He works at a homeless shelter and states his boss asked him to come and get checked out. A CXR is ordered that shows an abnormality in the apical region of the right upper lobe. Diagnosis and Treatment? Pulmonary Tuberculosis-Active History Risks for exposure Fever, night sweats, cough, weight loss, fatigue, and hemoptysis Physical Exam Usually non-specific but include dullness of lung sounds or occasional rales Studies Baseline LFTs, kidney function, CBC, and uric acid HIV and hepatitis testing CXR Sputum culture with AFB testing Baseline visual acuity and red-green discrimination when using ethambutol Pulmonary Tuberculosis-Active Treatment Initial phase consists of 2 months with rifampin, isoniazid, pyrazinamide, and ethambutol (RIPE) Continuation phase usually then continues with 4 months of isoniazid and rifampin Monitor for side effects 12
15 Pulmonary Tuberculosis-Active Initial Phase Continuation Phase Drugs Interval and doses Drugs Interval and doses INH RIF PZA EMB Seven days per week for 56 doses (8 weeks) or 5 days/week for 40 doses (8 weeks) INH/RIF 7 d/wk for 18 weeks or 5d/wk for 18 weeks INH/RIF Twice weekly for 18 weeks INH/RPT Once weekly for 18 weeks Cavitation on CXR & (+) 2 months require 7 months continuation phase DOT HIV (-), negative no cavitation on CXR Case A 56 year old diabetic female presents to your outpatient clinic with fever, chills, and cough which has worsened over the past week. She states she had an URI 2 months ago and was treated with Azithromycin and improved. Currently her vitals are- Temp: 101 F, RR-20, HR-101, BP-126/88, and PO-97%. Her physical exams revealed rhonchi in the left lower lobe. Otherwise exam is unremarkable. Diagnosis and Treatment? Community Acquired Pneumonia (CAP) History Fevers, chills, cough, dyspnea, pleuritic chest pain, sputum production Inquire about recent antibiotic use, hospitalizations, or other risks Physical Exam Increased respiratory rate, increased pulse, rales, or rhonchi Studies CXR Optional blood work and sputum/blood cultures (Outpatient) 13
16 Community Acquired Pneumonia (CAP) Treatment Admit or Not to Admit? CURB-65 Confusion (based upon a specific mental test or new disorientation to person, place, or time) Urea (blood urea nitrogen in the United States) >7 mmol/l (20 mg/dl) Respiratory rate >30 breaths/minute Blood pressure (systolic <90 mmhg or diastolic <60 mmhg) Age >65 years Community Acquired Pneumonia (CAP) Treatment Monitor for increased risk of drug resistant strains Age >65 years Recent ABX use in past 3 months Alcoholism Medical comorbidities Immunosuppressive illness or therapy Environmental exposures Community Acquired Pneumonia (CAP) Treatment No comorbidities or recent ABX use Macrolids or Doxycycline Doxycycline is preferred if concern of QT prolongation Treatment length is at least 5 days and 48 to 72 without fever Comorbidities or recent ABX use Respiratory fluoroquinolone OR beta-lactam effective against S. pneumoniae PLUS a macrolid or doxycycline Follow-up CXR Vaccination 14
17 Questions 15
AUGUST 25-27, 2017 UPDATE & BOARD REVIEW. acofp INTENSIVE. Pulmonary Predicaments in Primary Care. Peter F. Bidey, DO
acofp INTENSIVE UPDATE & BOARD REVIEW AUGUST 25-27, 2017 Loews Chicago O'Hare Hotel Rosemont, IL INNOVATIVE COMPREHENSIVE HANDS-ON Pulmonary Predicaments in Primary Care Peter F. Bidey, DO acofp Am eric
More informationCOPD: Current Medical Therapy
COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for
More informationCOPD/Asthma. Prudence Twigg, AGNP
COPD/Asthma Prudence Twigg, AGNP COPD/Asthma Qualifying Diagnosis Known diagnosis of COPD/asthma or CXR showing COPD with hyperinflated lungs and no infiltrates + two or more: Wheezing, SOB, increased
More informationCOPD: A Renewed Focus. Disclosures
COPD: A Renewed Focus Heath Latham, MD Assistant Professor Division of Pulmonary and Critical Care Medicine Disclosures No Business Interests No Consulting No Speakers Bureau No Off Label Use to Discuss
More informationASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?
ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,
More informationChronic Obstructive Pulmonary Disease Guidelines and updates
Chronic Obstructive Pulmonary Disease Guidelines and updates October 20, 2018 Saratoga Springs, NY COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United
More informationCOPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.
1 Definition of COPD: COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis. Airflow obstruction may be accompanied by airway hyper-responsiveness
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More information62 year old man with a cough! Dr. Aflah Sadikeen Consultant Respiratory Physician Colombo
62 year old man with a cough! Dr. Aflah Sadikeen Consultant Respiratory Physician Colombo History Mr.KS, a 62 year-old, has been feeling unwell - Worsening cough for the last 5 days - Feels out of breath
More informationAsthma 2015: Establishing and Maintaining Control
Asthma 2015: Establishing and Maintaining Control Webinar for Michigan Center for Clinical Systems Improvement (Mi-CCSI) Karen Meyerson, MSN, APRN, NP-C, AE-C June 16, 2015 Asthma Prevalence Approx. 26
More informationChronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease 07 Contributor Dr David Tan Hsien Yung Definition, Diagnosis and Risk Factors for (COPD) Differential Diagnoses Goals of Management Management of COPD THERAPY AT EACH
More informationUpdate on heterogeneity of COPD, evaluation of COPD severity and exacerbation
Update on heterogeneity of COPD, evaluation of COPD severity and exacerbation Yung-Yang Liu, MD Taipei Veterans General Hospital Aug 29, 2015 G O lobal Initiative for Chronic bstructive L D ung isease
More informationCOPD exacerbation. Chiara Maruggi, PGY2
COPD exacerbation Chiara Maruggi, PGY2 Learning objectives At the end of this lecture students will be able to: 1) Critically assess patients for COPD and design a management plan. 2) Develop a step-wise
More informationDisclosure and Conflict of Interest 8/15/2017. Pharmacist Objectives. At the conclusion of this program, the pharmacist will be able to:
Digging for GOLD Rebecca Young, PharmD, BCACP, Roosevelt University College of Pharmacy Assistant Professor of Clinical Sciences Practice Site Advocate Medical Group-Nesset Pavilion Disclosure and Conflict
More information2/12/2015. ASTHMA & COPD The Yin &Yang. Asthma General Information. Asthma General Information
ASTHMA & COPD The Yin &Yang Arizona State Association of Physician Assistants March 6, 2015 Sedona, Arizona Randy D. Danielsen, PhD, PA-C, DFAAPA Dean & Professor A.T. Still University Asthma General Information
More informationGOALS AND INSTRUCTIONAL OBJECTIVES
October 4-7, 2004 Respiratory GOALS: GOALS AND INSTRUCTIONAL OBJECTIVES By the end of the week, the first quarter student will have an in-depth understanding of the diagnoses listed under Primary Diagnoses
More informationAsthma ASTHMA. Current Strategies for Asthma and COPD
Current Strategies for Asthma and COPD Talmadge E. King, Jr., M.D. Krevins Distinguished Professor of Medicine Chair, Department of Medicine University of California San Francisco (UCSF) San Francisco,
More informationProvider Respiratory Inservice
Provider Respiratory Inservice 2 Welcome Opening Remarks We will cover: Definition of Asthma & COPD Evidence based guidelines for diagnosis, evaluation, and management of asthma Evidence based guidelines
More informationPrimary Care Medicine: Concepts and Controversies Wed., February 17, 2010 Fiesta Americana Puerto Vallarta, Mexico Update on Asthma and COPD
Primary Care Medicine: Concepts and Controversies Wed., February 17, 2010 Fiesta Americana Puerto Vallarta, Mexico Update on Asthma and COPD Talmadge E. King, Jr., M.D. Krevins Distinguished Professor
More informationCHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MOUSTAPHA ABIDALI, DO CRITICAL CARE FELLOW UNIVERSITY OF ARIZONA- PHOENIX
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MOUSTAPHA ABIDALI, DO CRITICAL CARE FELLOW UNIVERSITY OF ARIZONA- PHOENIX COPD OUTLINE Definition and Overview Pathophysiology Diagnosis and Assessment Therapeutic
More informationAmanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ
Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ Financial Disclosures Advanced Practiced Advisory Board for Circassia Learning Objectives 1. Briefly
More informationRESPIRATORY EMERGENCIES. Michael Waters MD April 2004
RESPIRATORY EMERGENCIES Michael Waters MD April 2004 ASTHMA Asthma is a chronic inflammatory disease of the airways with variable or reversible airway obstruction Characterized by increased sensitivity
More informationCOPD GOLD Guidelines & Barnet inhaler choices. Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust
COPD GOLD Guidelines & Barnet inhaler choices Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust GOLD 2017 Report: Chapters 1. Definition and Overview 2. Diagnosis and Initial
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
Page 1 of 9 PURPOSE To assure that DOP inmates with Pulmonary Diseases are receiving high quality Primary Care for their condition. POLICY All DOP Primary Care Providers and Chronic Disease Nurses are
More informationAsthma COPD Overlap (ACO)
Asthma COPD Overlap (ACO) Dr Thomas Brown Consultant Respiratory Physician Thomas.Brown@porthosp.nhs.uk Dr Hitasha Rupani Consultant Respiratory Physician Hitasha.rupani@porthosp.nhs.uk What is Asthma
More informationTuberculosis Tools: A Clinical Update
Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary
More informationImproving the Management of Asthma to Improve Patient Adherence and Outcomes
Improving the Management of Asthma to Improve Patient Adherence and Outcomes Robert Sussman, MD Atlantic Health System Overlook Medical Center Asthma Remains a Serious Health Risk in the US Every day in
More informationSCREENING AND PREVENTION
These protocols are designed to implement standard guidelines, based on the best evidence, that provide a consistent clinical experience for AHC II Integrated Clinical Delivery Network patients and allow
More informationDisclosure Statement. Epidemiological Data
EVALUATION OF THE MEDICATION UTILIZATION OF COPD PATIENTS AT THE MIAMI VA HEALTHCARE SYSTEM Simone Edgerton, PharmD. PGY 1 Pharmacy Resident Miami VA Healthcare System Miami, Florida Simone.edgerton2@va.gov
More informationRESPIRATORY CARE IN GENERAL PRACTICE
RESPIRATORY CARE IN GENERAL PRACTICE Definitions of Asthma and COPD Asthma is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airways so they
More informationGuideline for the Diagnosis and Management of COPD
Guideline for the Diagnosis and Management of COPD Introduction Chronic obstructive pulmonary disease (COPD) is a respiratory disorder largely caused by smoking. It is characterized by progressive, partially
More informationCOPD and Asthma Update. April 29 th, 2017 Rachel M Taliercio, DO Staff, Respiratory Institute
COPD and Asthma Update April 29 th, 2017 Rachel M Taliercio, DO Staff, Respiratory Institute What we ll be talking about COPD: diagnosis, management of stable COPD, COPD exacerbations Asthma: diagnosis,
More informationFundamentals of Tuberculosis (TB)
TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationDecramer 2014 a &b [21]
Buhl 2015 [19] Celli 2014 [20] Decramer 2014 a &b [21] D Urzo 2014 [22] Maleki-Yazdi 2014 [23] Inclusion criteria: Diagnosis of chronic obstructive pulmonary disease; 40 years of age or older; Relatively
More informationInhaler Confusion. Today s Speaker Dr. Randall Brown. Director of Asthma Programs 6/7/2016. Dr. Randall Brown March 31, 2016
+ Inhaler Confusion Dr. Randall Brown March 31, 2016 + Today s Speaker Dr. Randall Brown Director of Asthma Programs Center for Managing Chronic Disease University of Michigan 1 ASTHMA ESSENTIALS IN PRIMARY
More informationPulmonary Pearls. Medical Pearls. Case 1: Case 1 (cont.): Case 1: What is the Most Likely Diagnosis? Case 1 (cont.):
Pulmonary Pearls Christopher H. Fanta, MD Pulmonary and Critical Care Division Brigham and Women s Hospital Partners Asthma Center Harvard Medical School Medical Pearls Definition: Medical fact that is
More informationRespiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician
Respiratory Disease Dr Amal Damrah consultant Neonatologist and Paediatrician Signs and Symptoms of Respiratory Diseases Cardinal Symptoms Cough Sputum Hemoptysis Dyspnea Wheezes Chest pain Signs and Symptoms
More informationDiagnosis and Treatment of Tuberculosis, 2011
Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is
More informationFunction of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration)
Function of the Respiratory System Exchange CO2 (on expiration) for O2 (on inspiration) Upper Respiratory Tract Includes: Nose Mouth Pharynx Larynx Function: Warms and humidifies the inspired air Filters
More informationAsthma - Chronic. Presentations of asthma Cough Wheeze Breathlessness Chest tightness
Asthma - Chronic Definition of asthma Chronic inflammatory disease of the airways 3 components: o Reversible and variable airflow obstruction o Airway hyper-responsiveness to stimuli o Inflammation of
More informationTreatment Responses. Ronald Dahl, Aarhus University Hospital, Denmark
Asthma and COPD: Are They a Spectrum Treatment Responses Ronald Dahl, Aarhus University Hospital, Denmark Pharmacological Treatments Bronchodilators Inhaled short-acting β -Agonist (rescue) Inhaled short-acting
More informationExercise-Induced Bronchospasm. Michael A Lucia, MD, FCCP Asst Clinical Professor, UNR School of Medicine Sierra Pulmonary & Sleep Institute
Exercise-Induced Bronchospasm Michael A Lucia, MD, FCCP Asst Clinical Professor, UNR School of Medicine Sierra Pulmonary & Sleep Institute EIB Episodic bronchoconstriction with exercise May be an exacerbation
More informationCOPD COPD. Update on COPD and Asthma
Update on COPD and Asthma Talmadge E. King, Jr., M.D. Krevins Distinguished Professor of Medicine Chair, Department of Medicine University of California San Francisco (UCSF) San Francisco, CA COPD COPD
More informationChronic obstructive lung disease. Dr/Rehab F.Gwada
Chronic obstructive lung disease Dr/Rehab F.Gwada Obstructive lung diseases Problem is in the expiratory phase Lung disease Restrictive lung disease Restriction may be with, or within the chest wall Problem
More informationBasic mechanisms disturbing lung function and gas exchange
Basic mechanisms disturbing lung function and gas exchange Blagoi Marinov, MD, PhD Pathophysiology Department, Medical University of Plovdiv Respiratory system 1 Control of breathing Structure of the lungs
More informationI tri r n i si s c E t x ri r n i si s c
Problems with Oxygenation Lemone and Burke Chapter 36-39 39 Objectives Review anatomy and physiology of respiratory system. Describe changes associated with aging. Review O2 delivery systems Explain maintenance
More informationIn 2002, it was reported that 72 of 1000
REPORTS Aligning Patient Care and Asthma Treatment Guidelines Eric Cannon, PharmD Abstract This article describes how the National Asthma Education and Prevention Program Guidelines for the Diagnosis and
More informationHow to treat COPD? What is the mechanism of dyspnea? Smoking cessation
: The Increasing Role of the FP Alan Kaplan, MD, CCFP(EM) Presented at the Primary Care Today: Education Conference and Medical Exposition, Toronto, Ontario, May 2006. Chronic obstructive pulmonary disease
More information9/18/2010. Diagnostic Tests Pulse Oximetry Monitor O2 sat Normal % CBC Infection present? Oxygen carrying capacity?
3 4 5 6 Problems with Oxygenation Lemone and Burke Chapter 36-39 Objectives Review anatomy and physiology of respiratory system. Describe changes associated with aging. Review O delivery systems Explain
More informationADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.
ADULT ASTHMA GUIDE SUMMARY This summary provides busy health professionals with key guidance for assessing and treating adult asthma. Its source document Asthma and Respiratory Foundation NZ Adult Asthma
More informationCOPD Management in LTC: Presented By: Jessica Denney RRT
COPD Management in LTC: Presented By: Jessica Denney RRT Sponsored by Z & D Medical Services, Diamond Sponsor Seizing Opportunities to Provide Individualized Treatment and Device Selection for your COPD
More informationCOPD. Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS
IN THE NAME OF GOD COPD Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS Definition of COPD* COPD is a preventable and treatable chronic lung disease characterized by airflow limitation that is not fully
More informationMAYA RAMAGOPAL M.D. DIVISION OF PULMONOLOGY & CYSTIC FIBROSIS CENTER
MAYA RAMAGOPAL M.D. DIVISION OF PULMONOLOGY & CYSTIC FIBROSIS CENTER 16 year old female with h/o moderate persistent asthma presents to the ED after 6 hours of difficulty breathing, cough, and wheezing
More informationLecture Notes. Chapter 3: Asthma
Lecture Notes Chapter 3: Asthma Objectives Define asthma and status asthmaticus List the potential causes of asthma attacks Describe the effect of asthma attacks on lung function List the clinical features
More informationJOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES
JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES Authors Dr Ian Benton Respiratory Consultant COCH Penny Rideal Respiratory Nurse COCH Kirti Burgul Respiratory Pharmacist COCH Pam
More informationOPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING 10/16/2018 DISCLOSURES I have no financial or other disclosures
OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING J. Michael Fuller, MD, MEd, FACP, FCCP Associate Professor of Medicine University of South Carolina Greenville DISCLOSURES I have no financial or other
More informationAsthma in the Athlete
Asthma in the Athlete Jorge E. Gomez, MD Associate Professor Texas Children s Hospital Baylor College of Medicine Assist Team Physician UH Understand how we diagnose asthma Objectives Be familiar with
More informationCOPD Diagnosis, Management and Program
COPD Diagnosis, Management and Program RYAN MARTIN, MD NEBRASKA PULMONARY SPECIALTIES Initial diagnosis Setting matters: Inpatient. Usually sicker, oftentimes avoiding healthcare. Outpatient. Often seeking
More informationClinical Practice Guideline: Asthma
Clinical Practice Guideline: Asthma INTRODUCTION A critical aspect of the diagnosis and management of asthma is the precise and periodic measurement of lung function both before and after bronchodilator
More informationIntegrated Cardiopulmonary Pharmacology Third Edition
Integrated Cardiopulmonary Pharmacology Third Edition Chapter 13 Pharmacologic Management of Asthma, Chronic Bronchitis, and Emphysema Multimedia Directory Slide 7 Slide 12 Slide 60 COPD Video Passive
More informationDiagnosis, Treatment and Management of Asthma
Diagnosis, Treatment and Management of Asthma Asthma is a complex disorder characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation.
More informationUnconscious exchange of air between lungs and the external environment Breathing
Respiration Unconscious exchange of air between lungs and the external environment Breathing Two types External Exchange of carbon dioxide and oxygen between the environment and the organism Internal Exchange
More informationGINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017
GINA At-A-Glance Asthma Management Reference for adults, adolescents and children 6 11 years Updated 2017 This resource should be used in conjunction with the Global Strategy for Asthma Management and
More informationTB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012
TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release
More informationCOPD: From Hospital to Home October 5, 2015 Derek Linderman, MD Associate Professor COPD Center Pulmonary Nodule Clinic
COPD: From Hospital to Home October 5, 2015 Derek Linderman, MD Associate Professor COPD Center Pulmonary Nodule Clinic Learning Objectives Know the adverse effects of COPD exacerbations Know mainstays
More informationAsthma. UVM. University of Vermont. Alicia Jacobs MD Fletcher Allen Health Care and the University of Vermont
University of Vermont ScholarWorks @ UVM Family Medicine Scholarly Works 6-14-2013 Asthma Alicia Jacobs MD Fletcher Allen Health Care and the University of Vermont Follow this and additional works at:
More informationLecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)
Lecture Notes Chapter 4: Chronic Obstructive Pulmonary Disease (COPD) Objectives Define COPD Estimate incidence of COPD in the US Define factors associated with onset of COPD Describe the clinical features
More informationAsthma in Pediatric Patients. DanThuy Dao, D.O., FAAP. Disclosures. None
Asthma in Pediatric Patients DanThuy Dao, D.O., FAAP Disclosures None Objectives 1. Discuss the evaluation and management of asthma in a pediatric patient 2. Accurately assess asthma severity and level
More informationCOPD. Helen Suen & Lexi Smith
COPD Helen Suen & Lexi Smith What is COPD? Chronic obstructive pulmonary disease: a non reversible, long term lung disease Characterized by progressively limited airflow and an inability to perform full
More informationWhat is this patient s diagnosis?
Asthma and COPD KANTA VELAMURI, MD ASSOCIATE PROFESSOR OF MEDICINE PULMONARY, CRITICAL CARE AND SLEEP MEDICINE SECTION MICHAEL E. DEBAKEY VA MEDICAL CENTER BAYLOR COLLEGE OF MEDICINE Disclosures None Case
More informationPresented by UIC College of Nursing
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long-acting inhalers and emergency use inhalers.
More informationChronic Obstructive Pulmonary Disease 1/18/2018
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long acting inhalers and emergency use inhalers.
More informationFact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD)
Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD) Jin S. Oh, PharmD Larkin Community Hospital January 10, 2016 Fact COPD is the third leading cause of death in the United
More informationASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides
BRONCHIAL ASTHMA ASTHMA Epidemiology Pathophysiology Diagnosis 2 CHILDHOOD ASTHMA Childhood bronchial asthma is characterized by Airway obstruction which is reversible Airway inflammation Airway hyper
More informationChronic obstructive pulmonary disease
0 Chronic obstructive pulmonary disease Implementing NICE guidance June 2010 NICE clinical guideline 101 What this presentation covers Background Scope Key priorities for implementation Discussion Find
More informationAsthma Pathophysiology and Treatment. John R. Holcomb, M.D.
Asthma Pathophysiology and Treatment John R. Holcomb, M.D. Objectives Definition of Asthma Epidemiology and risk factors of Asthma Pathophysiology of Asthma Diagnostics test of Asthma Management of Asthma
More informationHQO s Episode of Care for Chronic Obstructive Pulmonary Disease
HQO s Episode of Care for Chronic Obstructive Pulmonary Disease Dr. Chaim Bell, MD PhD FRCPC Ontario Hospital Association Webcast October 23, 2013 Objectives 1. Describe the rationale and methodology for
More informationCOPD. Breathing Made Easier
COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought
More informationGlobal Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health
Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions
More informationAsthma and COPD. Health Net Provider Educational Webinar
Asthma and COPD Health Net Provider Educational Webinar AstraZeneca 2015 Disclosures Presenters today are employed by Astra Zeneca and have nothing to disclose. This presentation is free from bias. 2 Objectives
More informationCARE OF THE ADULT COPD PATIENT
CARE OF THE ADULT COPD PATIENT Target Audience: The target audience for this clinical guideline is all MultiCare providers and staff including those associated with our Clinically Integrated Network. The
More informationCOPD. Stan Kellar, MD. Physiology 11/4/2014. Chief of Clinical Affairs, BH NLR Pulmonary Medicine Sleep Medicine
Stan Kellar, MD Chief of Clinical Affairs, BH NLR Pulmonary Medicine Sleep Medicine COPD Physiology The lungs are filters Filter in oxygen Filter out carbon dioxide (Vascular filter, not part of this discussion)
More informationChronic Obstructive Pulmonary Disease
Scope of Problem Chronic Obstructive Pulmonary Disease Marianne J. Davies, RN, MSN, APRN Yale University School of Medicine Yale Comprehensive Cancer Center Nevada Cancer Institute 2005 Hospitalizations
More informationOver the last several years various national and
Recommendations for the Management of COPD* Gary T. Ferguson, MD, FCCP Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American
More informationTHE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause
More informationAir Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.
Asthma Air Flow Limitation In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation. True whether reversible, asthma and exercise-induced bronchospasm,
More informationCOPD/ Asthma. Dr Heather Lewis Honorary Clinical Lecturer
COPD/ Asthma Dr Heather Lewis Honorary Clinical Lecturer Objectives To understand the pathogenesis of asthma/ COPD To recognise the clinical features of asthma/ COPD To know how to diagnose asthma/ COPD
More informationLearning Objective. Asthma. Discuss the pathophysiology, clinical presentation, diagnosis, and treatment of Asthma 2/22/2017
Marianne Curran, PA C 3/1/17 Learning Objective Discuss the pathophysiology, clinical presentation, diagnosis, and treatment of Definition many variations Chronic Disorder with Reversible (Intermittent
More informationDifferential diagnosis
Differential diagnosis The onset of COPD is insidious. Pathological changes may begin years before symptoms appear. The major differential diagnosis is asthma, and in some cases, a clear distinction between
More informationII: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical
Table 3.1. Classification of COPD Severity Stage Pulmonary Function Test Findings Symptoms I: Mild Mild airflow limitations +/ Chronic cough and sputum production; patient unaware of abnormal FEV 1 80%
More informationPULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D.
PULMONARY MEDICINE BOARD REVIEW Christopher H. Fanta, M.D. Pulmonary and Critical Care Division Brigham and Women s Hospital Partners Asthma Center Harvard Medical School Financial Conflicts of Interest
More informationCommon Pulmonary Problems. Diana Coffa, MD Residency Program Director UCSF Department of Family and Community Medicine
Common Pulmonary Problems Diana Coffa, MD Residency Program Director UCSF Department of Family and Community Medicine Patrick J. Lynch, medical illustrator; C. Carl Jaffe, MD, cardiologist Obstructive
More informationRespiratory Diseases and Disorders
Chapter 9 Respiratory Diseases and Disorders Anatomy and Physiology Chest, lungs, and conducting airways Two parts: Upper respiratory system consists of nose, mouth, sinuses, pharynx, and larynx Lower
More informationThe Respiratory System
130 20 The Respiratory System 1. Define important words in this chapter 2. Explain the structure and function of the respiratory system 3. Discuss changes in the respiratory system due to aging 4. Discuss
More informationDiagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma
Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma
More informationKnown Allergies: Shellfish. Symptoms: abdominal pain, nausea, diarrhea, or vomiting. congestion, trouble breathing, or wheezing.
CSTAR CASE STUDIES: BLOCK B Asthma or COPD? Setting: Walk in clinic. Dan: I havi g that cough thi g agai HPI: Dan is a 49-year-old male teacher who reports having had episodes of cough with mucus production
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More informationCurrent Approaches to Asthma & COPD
10/11/18 Current Approaches to Asthma & COPD Lekshmi Santhosh, M.D. Assistant Professor, Pulm/Critical Care & Hosp Med Primary Care Medicine: Principles & Practice 10.11.2018 Revisiting the Dutch Hypothesis:
More information